ImmPACT Bio Revenue
Biotechnology Research • 
Los Angeles, California, United States • 21-50 Employees
ImmPACT Bio revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $200,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,000,000 |
| Total funding | No funding |
Key Contacts at ImmPACT Bio
Yang Qiu
Director, Msat
Sujita Sukumaran
Associate Director, Process Development
Alvin Caballero
Director, Manufacturing
Shirin Ghavam
Executive Director, Program And Alliance Management
Jenny Cui
Director, Discovery Research And Preclinical Development
Omar Pugach
Associate Director Quality Assurance
Cecilia D'Alterio
Associate Director, Procurement
Company overview
| Headquarters | 8501 Fallbrook Ave, 200, West Hills, California 91304, US |
| Phone number | +18188574828 |
| Websites | |
| NAICS | 541714 |
| Keywords | Biotechnology, Research, Oncology, Immunotherapy, Cancer Therapy, Lupus, Autoimmune, Car-T, Logic Gate, On Target Off Tumor Toxicity, Selective Treatment |
| Employees | 21-50 |
| Socials |
ImmPACT Bio Email Formats
ImmPACT Bio uses 4 email formats. The most common is {first name} (e.g., john@ucla.edu), used 52.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@ucla.edu | 52.6% |
{first name}{last name} | johndoe@ucla.edu | 42.1% |
{last name} | doe@ucla.edu | 5.3% |
About ImmPACT Bio
ImmPACT Bio is now part of Lyell Immunopharma. Learn how we are continuing to advance next-generation cell therapies that offer patients improved outcomes @Lyell or www.lyell.com. About ImmPACT Bio: ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
ImmPACT Bio has 21 employees across 6 departments.
Departments
Number of employees
Funding Data
ImmPACT Bio has never raised funding before.
Saudi Arabia
Australia
Canada
Frequently asked questions
4.8
40,000 users
